Background
==========

Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV2) \[[@b1-anntransplant-25-e925755]\]. The disease was initially confirmed in China and then rapidly spread worldwide with more than 2 million infected individuals and over 200 000 deaths worldwide \[[@b2-anntransplant-25-e925755]\]. This disease is especially fatal in elderly patients (patients older than 70 years) with comorbidities \[[@b3-anntransplant-25-e925755]\]. Most published data regarding COVID-19 and organ transplant recipients is nonspecific and lacks quality evidence. Data about demographics, characteristics, and clinical presentations of COVID-19 in kidney transplant recipients is scarce \[[@b4-anntransplant-25-e925755]\]. In this study, we aimed to review the published literature regarding kidney transplant patients who encountered COVID-19.

Methods
=======

Literature search
-----------------

A systematic literature review was performed using PubMed and ScienceDirect databases to identify relevant English-language articles published through May 6, 2020. Search terms included COVID-19, coronavirus, severe acute respiratory syndrome coronavirus 2, 2019-nCoV, SARS-CoV-2, SARS-CoV, MERS-CoV and transplantation. All article types were included: case reports, case series, commentaries, and review articles. A search in the database of the COVID-19 global research on coronavirus disease section of the World Health Organization (WHO) website through May 6, 2020 was performed using the following criteria: transplantation without any additional limits or filters \[[@b5-anntransplant-25-e925755]\]. Additional articles were retrieved by screening the reference lists of the included studies. The search strategy was approved and reviewed by all authors.

Eligibility criteria and study selection
----------------------------------------

The authors independently reviewed the titles and abstracts for inclusion. [Figure 1](#f1-anntransplant-25-e925755){ref-type="fig"} displays the flow diagram for this systematic review, based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2009 \[[@b6-anntransplant-25-e925755]\]. Databases were screened, filtered, and assessed for eligibility. Cases of COVID-19 in kidney transplant patients were included in this study. Articles with unrelated topics and/or with missed information were excluded.

Risk of bias
------------

The National Institutes of Health Quality Assessment Tool for Case Series Studies was used to qualify the reviewed articles \[[@b7-anntransplant-25-e925755]\]. [Table 1](#t1-anntransplant-25-e925755){ref-type="table"} shows the results of the 2 reviewers who independently rated the quality of the included studies.

Data extraction and synthesis
-----------------------------

Data was independently extracted from reports by 2 reviewers. All reported patients' demographic and clinical characteristics (country, age, sex, time from transplant, donor type, comorbidities, clinical presentation and maximum body temperature, initial complete blood count (CBC), C-reactive protein (CRP), baseline creatinine (Cr), blood urea nitrogen (BUN), renal involvement, baseline immunosuppressant medications, need for intensive care unit (ICU) and mechanical ventilation (MV), duration of illness and outcomes) were extracted, collected and analyzed. Due to the lack of sufficient data, a meta-analysis to assess the association of various patients' findings with demographic data, disease and patient characteristics, or outcomes was not performed. The principal summary measures used were the median, mean, standard deviation, and incidence.

Results
=======

Overview of the included studies
--------------------------------

A total of 493 articles were retrieved using the search strategy. After duplication removal, 378 articles were screened; 331 articles were excluded due to unrelated content. The remaining 47 articles were assessed for eligibility through full-text screening. There were 15 articles excluded due to unrelated content or lack of relevant information. There were 32 articles included but only 21 articles reported kidney transplant recipients encountered COVID-19 ([Figure 1](#f1-anntransplant-25-e925755){ref-type="fig"}). For quality assessment, we used the NIH Quality Assessment Tool for Case Series Studies \[[@b7-anntransplant-25-e925755]\]. Five case series and 16 case reports included 58 kidney transplant patients encountered COVID-19. Patients' characteristics and demographics were included in [Tables 2](#t2-anntransplant-25-e925755){ref-type="table"}[](#t3-anntransplant-25-e925755){ref-type="table"}--[4](#t4-anntransplant-25-e925755){ref-type="table"}.

Patients demographics and characteristics
-----------------------------------------

The 21 articles reported 58 kidney transplant patients who encountered COVID-19. There were 20 patients from China, 14 patients from the USA, 9 patients from Spain, 7 patients from the United Kingdom, 5 patients from Italy, 2 patients from Korea, and 1 patient from Turkey. There were 44 male patients (75.9%) and 14 female patients (14 out of 58; 24.1%). The mean age was 52.69 years (range, 24 to 80 years). Transplants were from unknown decreased persons in 16 cases (27.5%), living donors in 9 cases (15.5%), DCD (donor after cardiac death) in 6 cases (10.3%), DBD (donor after brain death) in 2 cases (3.4%), and the remaining 25 cases (43.1%) were from unknown sources. The mean post-transplant period was 7.68 years (range, 0.083 to 31 years). There were 9 patients (15.5%) who were within their first year after transplantation. The most common reported comorbidities were hypertension in 40 patients (68.9%), diabetes mellitus in 21 patients (36.2%), coronary artery/heart disease in 6 patients (10.3%), COPD in 2 patients (3.4%), and obesity in 3 patients (5.2%). In 11 patients (18.9%) there was no comorbidities reported. These variables are presented in the [Table 3](#t3-anntransplant-25-e925755){ref-type="table"}.

Clinical presentation
---------------------

The most frequently reported clinical presentation was fever; it was reported in 49 patients (84.5%) with a mean maximum temperature of 38.47°C (±0.79°C). Other reported clinical symptoms were cough (70%), shortness of breath (SOB) (56.9%), flu-like symptoms including myalgia and fatigue (60%), gastrointestinal symptoms including vomiting, diarrhea, nausea, abdominal pain/bloating and hyporexia/anorexia (44.8%), chills (17.2%), and chest pain/tightness/discomfort (6.9%). Less frequently reported symptoms included headache, dizziness, sore throat, rhinorrhea, nasal congestion, and stuffiness, coryza, dehydration, conjunctivitis, hematuria, and oliguria. These variables are presented in the [Table 3](#t3-anntransplant-25-e925755){ref-type="table"}.

Laboratory results
------------------

The initial white blood cell count median was 6×10^9^ (±3.4×10^9^). The initial median lymphocyte cell count was 0.6×10^9^ (±0.72×10^9^). Initial leukopenia and lymphopenia were reported in 22.8% and 63%, respectively. However, lymphopenia was eventually developed in 79% of patients. Median of the initial CRP was 49 mg/L (±92.4 mg/L) and high CRP (\>5 mg/dL) levels were noted in 97.2% of cases. Median of the baseline serum Cr was 1.65 mg/dL (±0.96 mg/dL) and 85% of patients had baseline serum Cr \>1.2 mg/dL. Median initial (post infection) serum Cr was 1.9 mg/dL (±1.7 mg/dL) and acute kidney injury (AKI) was observed in 28.2% of patients. High D-dimer (\>500 μg/L), ALT (\>50 U/L), AST (\>54 U/L), and LDH (\>225 U/L) levels were observed in 72.7%, 44%, 15%, and 69.2%, respectively. These variables are presented in the [Table 3](#t3-anntransplant-25-e925755){ref-type="table"}.

Immunosuppression management
----------------------------

Patients were treated with different immunosuppressive regimens though the most frequently reported regimen included tacrolimus (Tac), mycophenolate mofetil (MMF), and prednisone (Pred) which was reported in 33 patients (56.9%).

Pred was prescribed in 81% of patients and discontinued in 14.8%, increased in 4.2% and not changed in 80.8%. MMF was prescribed in 79.3% of patients and discontinued in 72%, reduced in 4.3%, and not changed in 15.2%. Tac was prescribed in 82.7% of patients and discontinued in 47.9%, reduced in 20.8%, and not changed in 25.8%. Other baseline immunosuppression medications were azathioprine, everolimus, ciclosporin, sirolimus, and mizoribine. These medications were held in some patients and not changed in others; 13.8% of patients recovered with no change in immunosuppression medications. These variables are presented in the [Table 4](#t4-anntransplant-25-e925755){ref-type="table"}.

Patients who died had their immunosuppression medications held (Tac 50%, MMF 100%, Pred 28.5%, ciclosporin 100%, sirolimus 100%, mizoribine100%), reduced (Tac 33.3%) or continued unchanged (Tac 16.6%, Pred 71.4%). These variables are presented in the [Table 5](#t5-anntransplant-25-e925755){ref-type="table"}.

Overall, patients had their immunosuppression medications held (Tac 47.9%, MMF 80.4%, Pred 14.8%, ciclosporin 50%, sirolimus 50%, mizoribine100%, azathioprine 50%), reduced (Tac 33.3%, MMF 4.3%) or continued unchanged (Tac 25.8%, MMF 15.2%, Pred 80.8%). Overall, 4.2% of patients were managed by increasing the dose of prednisone. These variables are presented in the [Table 4](#t4-anntransplant-25-e925755){ref-type="table"}.

COVID-19 directed management
----------------------------

Treatment targeted COVID-19 included antibiotics (41.3%), hydroxychloroquine (43.1%), intravenous methylprednisolone (32.7%), intravenous immunoglobulin (25.8%), lopinavir/ritonavir (20.6%), unspecified antivirals (17.2%), azithromycin (15.5%), oseltamivir (13.8%), interferon a,b (5.2%), tocilizumab (3.4%), and remdesivir (1.7%). These variables are presented in the [Table 4](#t4-anntransplant-25-e925755){ref-type="table"}.

COVID-10 targeting treatment used in patient who died included antibiotics (55.5%), hydroxychloroquine (55.5%), lopinavir/ritonavir (44.4%), intravenous methylprednisolone (33.3%), and intravenous immunoglobulin (22.2%).

Patients outcomes
-----------------

Overall, 19% of patients needed intensive care unit (ICU) admission and 22.4% of patients required mechanical ventilation (MV). Overall, 62% of patients recovered and were discharged with median of the illness duration of 17.5 days (range, 7 to 48 days). At the time of report publication, 22.4% of patients were alive and hospitalized, with median of the illness duration of 14 days (range, 7 to 49 days). Overall, 15.5% of patients had died with median of the illness duration of 9 days (range, 5 to 40 days).

Characteristics of patients who died
------------------------------------

The mean age was 66.2 years with 55.5% of patients older than 65 years; 55.5% of patients were male and the mean of the transplant age was 9.7 years. Hypertension, diabetes mellitus, and COPD were reported in 88.8%, 33.3%, and 100% of patients, respectively. In addition, 66.6% of patients had lymphopenia and 66.6% had high CRP serum levels. Acute kidney injury (AKI) was reported in 44.4% of patients ([Table 5](#t5-anntransplant-25-e925755){ref-type="table"}).

Pooled results
--------------

Three studies reported 36, 20, and 15 patients, respectively. These studies reported results without demographics and characteristics for each patient and thus were not included in our tabulated results. However, these 3 studies were used to draw pooled measures for all reported kidney transplant patients who encountered COVID-19, found in the literature. The total number of kidney transplant patients who encountered COVID-19 reported in the literature was 129 cases. The age mean was 54.2 years with 73.7% of the patients were males. The transplant age mean was 8.2 years with 65.4% of the transplants from a deceased source. Hypertension, diabetes mellitus, and coronary artery disease were reported in 82.6%, 40%, and 14% of cases, respectively. The most commonly reported presentations in order were fever (82.3%), cough (58%), SOB (33.2%), fatigue (30.7%), diarrhea (19.7%), myalgia (17.3%), sore throat (7.6%), and vomiting (6.9%) ([Table 6](#t6-anntransplant-25-e925755){ref-type="table"}).

The initial white blood cell count mean was 5.37×10^9^. The initial mean lymphocyte cell count was 0.77×10^9^. Leukopenia and lymphopenia were reported in 21.9% and 79% of patients, respectively. Mean initial CRP was 52.4 mg/L and high CRP (\>5 mg/dL) levels were noted in 71.6% of cases. Mean initial (post infection) serum Cr was 1.85 mg/dL and AKI was observed in 34.1% of patients. High D-dimer (\>500 μg/L) and lactate dehydrogenase (LDH, \>225 U/L) levels were observed in 64.8% and 52.6%, respectively. Kidney transplant patients encountered COVID-19 were maintained on Tac (92%), MMF (78.8%), Pred (77%), and azathioprine (5.2%) and were manage by holding MMF in 79.1% of patients and holding Tac in 34.4% of patients. These patients received treatments targeted for COVID-19 which included hydroxychloroquine (77.6%), lopinavir/ritonavir (49.8%), antibiotics (48%), azithromycin (40.5%), and tocilizumab (11.8%). Overall, 20% of patients needed ICU admission, 24.6% of patients required MV, 42% of patients recovered and were discharged, 41.3% of patients were alive and hospitalized at the time of the study publication, and 18.8% of patients had died ([Tables 6](#t6-anntransplant-25-e925755){ref-type="table"}, [7](#t7-anntransplant-25-e925755){ref-type="table"}).

Discussion
==========

Fever in COVID-19 has been reported in 99% of patients \[[@b18-anntransplant-25-e925755],[@b19-anntransplant-25-e925755]\]. Our study has found that 15% of the kidney transplant patients had no fever on presentation or during their hospitalization. On the other hand, cough, shortness of breath, myalgia, headache, sore throat, and gastrointestinal symptoms were more common than the typical COVID-19 presentation \[[@b18-anntransplant-25-e925755]--[@b21-anntransplant-25-e925755]\].

Additionally, this review found that there were several unreported symptoms that appeared in the COVID-19 positive kidney transplant patients, like chest tightness and pain, coryza, dehydration, conjunctivitis, dizziness, and weight loss \[[@b20-anntransplant-25-e925755]\]. Interestingly, the previously unreported chest tightness and pain symptoms in other cohorts had an incidence of 7% in this cohort.

COVID-19 causes of pneumonia can be severe enough to be lethal, especially in patients with advanced age or underlying medical comorbidities \[[@b22-anntransplant-25-e925755]\]. Those comorbidities include cardiovascular disease, diabetes mellitus, hypertension, chronic lung disease, cancer, chronic kidney disease, and obesity (body mass index ≥30 kg/m^2^) \[[@b3-anntransplant-25-e925755],[@b22-anntransplant-25-e925755]\]. Kidney transplant patients infected with COVID-19 are a fragile and high-risk group due to immunosuppressant medications (ISMs), kidney disease, and common comorbidities. In this review, 81% of patients had comorbidities, with diabetes mellitus and hypertension as the most common reported comorbidities. This fact exposes those patients to a more severe COVID-19 infection, not to mention the additional unclear risk of the immunosuppression. Kidney transplant recipients and candidates are as a rule in a high-risk group due to the high incidence and prevalence of hypertension, diabetes, obesity, and advanced age in this group.

It was previously reported that a progressive decline in lymphocyte count was observed in non-survivors compared to more stable levels in survivors \[[@b18-anntransplant-25-e925755]\]. In the present study, 66.6% of patients who died had lymphopenia. Given the fact that ISMs can induce lymphopenia, many kidney transplant patients can have a baseline lymphopenia that might further deteriorate and worsen the prognosis \[[@b8-anntransplant-25-e925755]\].

AKI, proteinuria, and hematuria have all been reported in COVID-19 patients. AKI has been reported to have occurred in 25% to 29% of critically ill COVID-19 patients in Wuhan, China \[[@b23-anntransplant-25-e925755],[@b24-anntransplant-25-e925755]\]. The incidence of AKI among patients who are less severely ill is unknown. In our cohort, AKI was reported in 28.2% of patients. However, the pooled AKI prevalence was 34.1% (see [Table 6](#t6-anntransplant-25-e925755){ref-type="table"}). This may indicate that kidney transplant patients infected with COVID-19 are more likely to have AKI than other cohorts. AKI has been associated with worse outcomes \[[@b25-anntransplant-25-e925755]\] and subsequently, kidney transplant patients infected with COVID-19 may have worse outcomes and mortality.

Several studies and a report from the Chinese Center for Disease Control and Prevention have classified COVID-19 severity \[[@b23-anntransplant-25-e925755],[@b26-anntransplant-25-e925755]\] as mild, severe, and critical disease that were reported in 81%, 14%, and 5% of patients. However, in our cohort, mild disease was only reported in 43% of patients while severe disease that presents with SOB or hypoxia was reported in 57% of patients.

The WHO reported that recovery time appears to be around 2 weeks for mild infections and 3 to 6 weeks for severe disease \[[@b27-anntransplant-25-e925755]\]. In this report, it appears that 62% of patients recovered clinically from the COVID-19 with a median duration of illness of 17.5 days (range, 7 to 48 days). Rates of ICU admission were reported to range between 5% to 12% while the rate of MV was 2.3% in the general population \[[@b28-anntransplant-25-e925755],[@b29-anntransplant-25-e925755]\]. In our cohort, 19% of patients were admitted to the ICU and 22.4% of patients required MV.

The most recently reported mortality rate of COVID-19 was 3.77% \[[@b30-anntransplant-25-e925755]\]. The mortality rate of kidney transplant patients infected with COVID-19 in this cohort was 15.5% (9 out of 58 patients) and the pooled mean was 18.8%. Despite the small number of patients included in the present study, this high mortality rate indicates that COVID-19 in kidney transplant patients may portend an ominous outcome. We found that 11.1% of the 1-year transplant age patients had died while 16.3% mortality was found for patients with transplant age more than 1 year.

It has been reported that 81% of COVID-19 patients present with mild disease and can be managed at home, while severe and critical COVID-19 disease should be managed with prompt hospitalization while ensuring appropriate infection control and supportive care \[[@b23-anntransplant-25-e925755],[@b31-anntransplant-25-e925755],[@b32-anntransplant-25-e925755]\]. The hospitalized patients should be managed with empiric treatment for bacterial pneumonia in selected patients, prevention of venous thromboembolism, and avoiding nebulized medications. The WHO and CDC recommend against systemic glucocorticoids in COVID-19 patients unless there are other indications \[[@b31-anntransplant-25-e925755],[@b32-anntransplant-25-e925755]\]. To date, all suggested medications are under investigation with no proven efficacy against COVID-19. These medications include remdesivir, hydroxychloroquine/chloroquine, azithromycin and hydroxychloroquine, convalescent plasma, tocilizumab, favipiravir, interferon beta, and lopinavir/ritonavir. A registry of international clinical trial can be found at *<https://www.clinicaltrials.gov/ct2/results?cond=covid19&term=&cntry=&state=&city=&dist>*. Most of our cohort had been hospitalized and could not be managed at home due to the severity of the disease. They had been managed with antibiotics (41.3%), hydroxychloroquine (43.1%), intravenous methylprednisolone (32.7%), intravenous immunoglobulin (25.8%), lopinavir/ritonavir (20.6%), unspecified antivirals (17.2%), azithromycin (15.5%), oseltamivir (13.8%), interferon a,b (5.2%), tocilizumab (3.4%), and remdesivir (1.7%).

The effect of immunosuppression on the progression of COVID-19 is not clear yet. There are 2 aspects that cannot be ignored when dealing with immunosuppression and COVID-19. Firstly, it was proven that COVID-19 patients have a high prevalence of lymphopenia \[[@b33-anntransplant-25-e925755]\] but it is not clear yet whether lymphopenia is a risk factor for COVID-19 or a result of it. Secondly, it is thought that the severity of COVID-19 may be the result of a hyperinflammatory response (cytokine storm). Thus, many have questioned the role of immunomodulation in the treatment of severe cases \[[@b34-anntransplant-25-e925755],[@b35-anntransplant-25-e925755]\].

Interestingly, D'Antiga from Italy recently published a study that concluded that immunocompromised patients do not have an increased risk of developing severe pulmonary disease compared to the general population \[[@b36-anntransplant-25-e925755]\].

Conclusions
===========

Kidney transplant patients may present with atypical clinical picture of the COVID-19. Fever may be absent while other atypical symptoms may prevail. Therefore, a high index of suspicion for COVID-19 and perhaps even surveillance in this population may help in early diagnosis and prevention of further transmission. The role of immunosuppression therapy should be assessed in every case individually.
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###### 

Quality ratings of included studies according to NIH quality assessment tool for case series studies.

  Study            Q 1   Q 2   Q 3   Q 4   Q 5   Q 6   Q 7   Q 8   Q 9   Reviewer 1   Reviewer 2
  ---------------- ----- ----- ----- ----- ----- ----- ----- ----- ----- ------------ ------------
  Banerjee         Yes   No    CD    Yes   CD    Yes   No    Yes   Yes   Fair         Fair
  Bartiromo        Yes   Yes   NA    NA    Yes   Yes   No    NA    Yes   Fair         Fair
  Chen             Yes   Yes   CD    No    Yes   Yes   Yes   NA    Yes   Fair         Fair
  Gandolfini       Yes   Yes   CD    Yes   Yes   Yes   Yes   NA    Yes   Fair         Fair
  Guillen          Yes   Yes   NA    NA    No    Yes   No    NA    Yes   Fair         Fair
  Huang            Yes   No    CD    Yes   Yes   No    Yes   NA    No    Poor         Poor
  Ning             Yes   Yes   NA    NA    Yes   Yes   Yes   NA    Yes   Fair         Fair
  Seminari         Yes   Yes   NA    NA    Yes   Yes   No    NA    Yes   Fair         Fair
  Wang             Yes   No    NA    NA    Yes   Yes   No    NA    Yes   Fair         Fair
  Zhang            Yes   Yes   CD    Yes   Yes   Yes   Yes   Yes   Yes   Fair         Fair
  Zhu              Yes   Yes   NA    NA    Yes   Yes   No    NA    Yes   Fair         Fair
  Arpali           Yes   No    CD    NA    CD    Yes   No    Yes   Yes   Fair         Fair
  Billah           Yes   No    CD    NA    CD    Yes   No    Yes   Yes   Fair         Fair
  Fernández-Ruiz   Yes   Yes   CD    NA    Yes   Yes   Yes   Yes   Yes   Fair         Fair
  Fontana          Yes   No    CD    NA    CD    Yes   No    Yes   Yes   Fair         Fair
  Hsu              Yes   No    CD    NA    Yes   Yes   No    Yes   Yes   Fair         Fair
  Johnson          Yes   Yes   NA    NA    CD    Yes   No    Yes   Yes   Fair         Fair
  Kates            Yes   No    CD    Yes   CD    Yes   Yes   Yes   Yes   Fair         Fair
  Kim              Yes   Yes   NA    Yes   Yes   Yes   No    Yes   Yes   Fair         Fair
  Nair             Yes   No    CD    Yes   Yes   Yes   Yes   Yes   Yes   Fair         Fair
  Zhu              Yes   Yes   NA    Yes   CD    Yes   Yes   Yes   Yes   Fair         Fair

NIH -- National Institutes of Health; NR -- not reported; CD -- cannot determine; NA -- not applicable. The NIH Quality Assessment Tool for Case Series Studies \[[@b7-anntransplant-25-e925755]\] poses nine questions: 1=Was the study question or objective clearly stated?, 2=Was the study population clearly and fully described, including a case definition?, 3=Were the cases consecutive?, 4=Were the subjects comparable?, 5=Was the intervention clearly described?, 6=Were the outcome measures clearly defined, valid, reliable, and implemented consistently across all study participants?, 7=Was the length of follow-up adequate?, 8=Were the statistical methods well-described?, 9=Were the results well-described?

###### 

Characteristics of all available reported kidney transplant recipients infected with COVID-19.

  Study; Country                                              Number                        Age; Sex                    Years post-Tx; Donor    Comorbidities             Clinical presentation; Max Temp                                                                            Initial WBCC, NC, LC (×10^9^/L)            Initial CRP (mg/L)                                                      Baseline Cr (mg/dL)[\^](#tfn3-anntransplant-25-e925755){ref-type="table-fn"}   Initial Cr (mg/dL)
  ----------------------------------------------------------- ----------------------------- --------------------------- ----------------------- ------------------------- ---------------------------------------------------------------------------------------------------------- ------------------------------------------ ----------------------------------------------------------------------- ------------------------------------------------------------------------------ --------------------
  Banerjee; UK \[[@b12-anntransplant-25-e925755]\]            \#1                           48;M                        31; deceased            HTN                       Cough, Fever, SOB; N/A                                                                                     N/A                                        N/A                                                                     3.96                                                                           N/A
                                                              \#2                           67;F                        1; DBD                  HTN, DM                   Cough, Fever, SOB, Hypoxia; N/A                                                                            6, N/A, 0.8                                83                                                                      1.7                                                                            2.54; AKI
                                                              \#3                           54;F                        0.25; deceased          DM, CMV infection         SOB, Hypoxia; N/A                                                                                          11.2, N/A, 0.5                             329                                                                     1                                                                              2.71; AKI
                                                              \#4                           65;M                        1.5; deceased           HTN                       SOB, Chest pain; N/A                                                                                       N/A                                        N/A                                                                     2                                                                              N/A
                                                              \#5                           69;F                        0.083; deceased         HTN, DM                   SOB, Fever, V/D; 39°C                                                                                      9.4, N/A, 0.3                              N/A                                                                     1.9                                                                            N/A
                                                              \#6                           54;M                        7; N/A                  HTN, HHA                  Cough, Fever; 38.5°C                                                                                       10, N/A, 4                                 N/A                                                                     1.6                                                                            2.1; AKI
                                                              \#7                           45;M                        2.5; N/A                HTN                       Fever, Flu-like symptoms, Cough, SOB, Hypoxia; N/A                                                         5.5, N/A, 0.3                              198                                                                     5.1                                                                            11; AKI
  Bartiromo; Italy \[[@b3-anntransplant-25-e925755]\]         \#1                           36; F                       25; deceased            SLS                       Cough, Coryza, Fatigue; 36.3°C                                                                             N/A, High, Normal                          67                                                                      1.5                                                                            1.77
  Chen; China \[[@b24-anntransplant-25-e925755]\]             \#1                           49; M                       6; DBD                  HTN                       Hyporexia, Cough, Fever, SOB; 38.6°C                                                                       3.4, 2.59, 0.4                             74                                                                      1.24                                                                           1.89
  Gandolfini; Italy \[[@b25-anntransplant-25-e925755]\]       \#1                           75; M                       10; deceased            COPD, HTN, Obesity, CAD   Fever, SOB, Flu-like symptoms; 37.5°C                                                                      6.5, N/A, 0.8                              180                                                                     2.1                                                                            2.2
                                                              \#2                           52; F                       0.66; DCD               HTN                       Fever, SOB, D, Flu-like symptoms; 37.5°C                                                                   2.5, N/A, 0.11                             158                                                                     1.3                                                                            2.4; AKI
  Guillen; Spain \[[@b26-anntransplant-25-e925755]\]          \#1                           50; M                       4; deceased             HTN, PTLD, SP             Fever, V, Dehydration, Cough, Conjunctivitis, Hypoxia; 38.2°C                                              10.5, N/A, 1.8 but developed lymphopenia   5                                                                       1.3                                                                            1.6; AKI
  Huang; China \[[@b27-anntransplant-25-e925755]\]            \#1                           58; M                       12; N/A                 None                      Cough, Fever, SOB, Hypoxia; 37.6°C                                                                         N/A but developed lymphopenia              N/A                                                                     N/A                                                                            N/A
  Ning; China \[[@b28-anntransplant-25-e925755]\]             \#1                           29; M                       1.5; Living             HTN                       Fever, Fatigue, Chills, Hyporexia, N/V, Chest tightness, nasal stuffiness, Dizziness, Hematuria; 37.7°C    11.4, N/A, 1.5                             N/A                                                                     N/A                                                                            1.1; AKI
  Seminari; Italy \[[@b29-anntransplant-25-e925755]\]         \#1                           50; M                       4; N/A                  HTN, DM                   Cough, Fever; 37.5°C                                                                                       3.5, 1.8, 1.2 but developed lymphopenia    18.6                                                                    N/A                                                                            1.7
  Wang; China \[[@b30-anntransplant-25-e925755]\]             \#1                           49; M                       2; N/A                  HTN, DM                   Fever, Respiratory symptoms; N/A                                                                           7, 6, 0.6                                  22.7                                                                    N/A                                                                            1.4
  Zhang; China \[[@b31-anntransplant-25-e925755]\]            \#1                           38; M                       0.5; DCD                None                      Cough, Fever; 38.9°C                                                                                       4.7, 2.6, 0.6                              6                                                                       N/A                                                                            1.1
                                                              \#2                           64; M                       4; DCD                  Bladder cancer            Fever, Anuria, Cough,, SOB, Flu-like symptoms; 38.3°C                                                      17.6, 16, 0.5                              337                                                                     N/A                                                                            4.6; AKI
                                                              \#3                           37; F                       0.66; DCD               HTN                       Cough, Fever; 39°C                                                                                         5.6, 3.9, 0.3                              9.7                                                                     N/A                                                                            1.5
                                                              \#4                           47; M                       1.2; DCD                None                      Cough, Fever, Flu-like symptoms; 39.8°C                                                                    4, 2.3, 0.5                                13.3                                                                    N/A                                                                            1.6
                                                              \#5                           38; M                       3; DCD                  HTN, DM                   Cough, Fever, Flu-like symptoms; 39.1°C                                                                    6.4, 3.2, 0.9                              33.7                                                                    N/A                                                                            1.5
  Zhu; China \[[@b32-anntransplant-25-e925755]\]              \#1                           52; M                       12; Living              None                      Fatigue, SOB, Chest tightness and pain, N, Hyporexia, Abd.P, Cough, Fever, Headache, Weight loss; 38.9°C   9, 7, 1.13 but developed lymphopenia       30                                                                      1.57                                                                           1.62
  Arpali; Turkey \[[@b37-anntransplant-25-e925755]\]          \#1                           28; F                       0.5; Living             LLS                       Fever, Fatigue, Sore throat, Rhinorrhea; 38°C                                                              3.1, N/A, 0.3                              5.7                                                                                                                                                    0.92
  Billa; USA \[[@b38-anntransplant-25-e925755]\]              \#1                           44; M                       7; deceased             None                      SOB; N/A                                                                                                                                                                                                                      2.3                                                                            2.3; AKI
  Fontana; Italy \[[@b39-anntransplant-25-e925755]\]          \#1                           61; M                       15; deceased            NMZL, PD, NB              Fever, Chills; 38°C                                                                                        5.4, 4.2, 1.2 but developed lymphopenia    41                                                                      1.5                                                                            1.9
  Hsu; USA \[[@b40-anntransplant-25-e925755]\]                \#1                           39; M                       3;                      DCM, DM, HTN, Obesity     Fever, Headache, Sore throat, Cough, SOB, Fatigue, Myalgia, Dizziness, Chills; 38.8°C                      2.5, N/A, 0.2                              67                                                                      1                                                                              0.85
  Kates, USA \[[@b41-anntransplant-25-e925755]\]              \#1                           54; M                       20; deceased            HTN, DM,                  Fever, Chills, Fatigue, Cough, SOB, N/V/D; 40°C                                                            6.2, N/A, 2 but developed lymphopenia                                                                              1.9                                                                            3.4; AKI
  Johnson; USA \[[@b42-anntransplant-25-e925755]\]            \#1                           57; M                       0.66; deceased          None                      Fever, Chills, Hyporexia, Abd. bloating, Back pain, Fatigue, Myalgia, SOB, Anorexia, D, Oliguria; 38.2°C   1.4, 0.7, 0.3                                                                                                      2                                                                              3.2;
  Kim; Korea \[[@b43-anntransplant-25-e925755]\]              \#1                           36; M                       4; Living               None                      Fever, Cough, Rhinorrhea, D, Oliguria, Chest discomfort; 38.5°C                                            6.6, 5.4, 0.6                              46                                                                      1.47                                                                           2
                                                              \#2                           46; M                       9; deceased             DM                        Cough; N/A                                                                                                 4, 2, 1.3                                  27                                                                      2                                                                              1.85
  Fernández-Ruiz; Spain \[[@b44-anntransplant-25-e925755]\]   \#1                           78; M                       8.3; N/A                HTN, Prostate CA          Fever, SOB                                                                                                                                                                                                                                                                                                   
                                                              \#2                           73; M                       1.8; N/A                HTN, DM                   Fever, SOB, Cough,                                                                                                                                                                                                                                                                                           
                                                              \#3                           80; M                       3.8; N/A                HTN, DM                   SOB, Cough, Myalgia, Hyporexia                                                                                                                                                                                                                                                                               
                                                              \#4                           71; F                       6; N/A                  HTN                       Fever, SOB, Cough, Sore throat                                                                                                                                                                                                                                                                               
                                                              \#5                           71; M                       30; N/A                 HTN, DM, CAD              Fever, Abd.P                                                                                                                                                                                                                                                                                                 
                                                              \#6                           76; M                       14.8; N/A               HTN, Obesity              Fever, Rhinorrhea                                                                                                                                                                                                                                                                                            
                                                              \#7                           39; M                       16.8; N/A               HTN                       Fever, Myalgia                                                                                                                                                                                                                                                                                               
                                                              \#8                           65: M                       6.5; N/A                HTN, DM, OSA              Fever, SOB, Cough                                                                                                                                                                                                                                                                                            
  Nair; USA \[[@b45-anntransplant-25-e925755]\]               \#1                           51; M                       0.42; deceased          HTN, DM, CAD              Fever, Chills, Cough                                                                                       9.2, N/A, 1.1                                                                                                                                                                                     0.88
                                                              \#2                           37; M                       7; living               HTN, DM                   Cough, Chills, Nasal congestion, Myalgia                                                                   5, N/A, 2.4                                180                                                                                                                                                    1.93
                                                              \#3                           63; F                       11.6; living            HTN                       Fever, Chills, Cough, Myalgia, Headache;                                                                   9, N/A, 1.2                                34                                                                                                                                                     1.2
                                                              \#4                           30; F                       3.7; living             HTN, DM                   Fever, Myalgia, Headache, V                                                                                3.7, N/A, 1.2                                                                                                                                                                                     1.5
                                                              \#5                           56; M                       20; deceased            HTN, DM                   Fever, Cough, Fatigue                                                                                      4, N/A, 0.3                                306                                                                                                                                                    4.8; AKI
                                                              \#6                           80; M                       13.8; living            HTN, DM, CAD              Fever, Chills, Fatigue, Myalgia, D                                                                         5, N/A, 0.2                                87                                                                                                                                                     1.9
                                                              \#7                           45; M                       3.4; deceased           HTN, DM                   Fever, Cough, Myalgia, D                                                                                   5.2, N/A, 1.1                              38                                                                                                                                                     1.74
                                                              \#8                           68; M                       11.6; N/A               HTN, DM                   Fever, Cough, SOB                                                                                          6.7, N/A, 0.5                              240                                                                                                                                                    1.46; AKI
                                                              \#9                           75; F                       8.6; living             HTN, CA                   Fever, Cough, SOB, Fatigue                                                                                 6.3, N/A, 0.4                              50                                                                                                                                                     1.3
                                                              \#10                          57; F                       11.6; deceased          HTN, DM                   Cough, SOB, Chills, Fatigue                                                                                11, N/N, 1.4                               230                                                                                                                                                    1.6; AKI
  Zhu; China \[[@b46-anntransplant-25-e925755]\]              \#1                           24; M                                               None                      Fever; 38°C                                                                                                N/A                                        30                                                                                                                                                     2.24
                                                              \#2                           55; M                                               CAD                       Cough, SOB, Fatigu                                                                                         N/A, N/A, 0.3                              80                                                                                                                                                     3.48
                                                              \#3                           29; M                                               None                      Fever, Cough, SOB, Fatigue, D; 38.8°C                                                                      N/A, N/A, 0.47                             118                                                                                                                                                    2.84
                                                              \#4                           30; M                                               HTN                       Fever, Cough, SOB, Fatigue; 39°C                                                                           N/A, N/A, 0.6                              42                                                                                                                                                     2.36
                                                              \#5                           50; M                                               HTN                       Fever, Cough, SOB, Fatigue; 38.6°C                                                                         N/A, N/A, 0.4                              40                                                                                                                                                     N
                                                              \#6                           65; F                                               None                      Fever, Cough, SOB, Fatigue, D; 38°C                                                                        N/A, N/A, 0.7                              40                                                                                                                                                     N
                                                              \#7                           52; M                                               HTN, CAD                  Fever, Cough, SOB, Fatigue; 38.9°C                                                                         N/A, N/A, 1                                54                                                                                                                                                     N
                                                              \#8                           49; M                                               None                      Fever, Cough, SOB, Fatigue, D; 39.2°C                                                                      N/A                                        49                                                                                                                                                     N
                                                              \#9                           59; M                                               HTN, COPD                 Fever, Cough, SOB, Fatigue; 38.4°C                                                                         N/A, N/A, 0.4                              100                                                                                                                                                    5.2; AKI
                                                              \#10                          37; F                                               HTN                       Fever, Cough, SOB, Fatigue; 40°C                                                                           N/A, N/A, 0.2                              34                                                                                                                                                     2.14
  **Study; Country**                                          **Initial D-dimer, (μg/L)**   **Initial ALT/AST (U/L)**   **Initial LDH (U/L)**   **Baseline ISMs**         **Management**                                                                                             **ICU & MV**                               **Outcomes**[\*](#tfn2-anntransplant-25-e925755){ref-type="table-fn"}                                                                                  
  Banerjee; UK \[[@b12-anntransplant-25-e925755]\]            N/A                           N/A                         N/A                     Aza, Pred                 No change in ISMs                                                                                          None                                       Recovered, N/A                                                                                                                                         
                                                              2032                          N/A                         1226                    Tac, MMF, Pred            Tac, MMF stopped, Abx                                                                                      Both                                       Died after 12d                                                                                                                                         
                                                              N/A                           N/A                         N/A                     Tac, MMF, Pred            Tac, MMF stopped, Abx, oseltamivir                                                                         MV                                         Alive but suffers, 7d                                                                                                                                  
                                                              N/A                           N/A                         N/A                     Tac, MMF, Pred            MMF stopped                                                                                                Both                                       Alive but suffers                                                                                                                                      
                                                              N/A                           N/A                         N/A                     Tac, MMF, Pred            MMF stopped, Abx, PC, furosemide, Blood transfusion                                                        ICU                                        Alive but suffers, 7d                                                                                                                                  
                                                              N/A                           N/A                         N/A                     Tac, MMF                  MMF stopped, PC                                                                                            None                                       Alive but suffers, 11d                                                                                                                                 
                                                              1907                          N/A                         502                     Tac, Aza, Pred            Aza stopped, Tac reduced, Pred increased, HD                                                               None                                       Recovered, 13d                                                                                                                                         
  Bartiromo; Italy \[[@b3-anntransplant-25-e925755]\]         N/A                           N/A                         N/A                     Tac, Pred                 Tac stopped, hydroxychloroquine, Abx, lopinavir/ritonavir (for 2 days), darunavir/cobicistat               None                                       Recovered, 14d                                                                                                                                         
  Chen; China \[[@b24-anntransplant-25-e925755]\]             N/A                           57/50                       N/A                     Tac, MMF, Pred            ISMs stopped, Ribavirin, Abx, IVIG, IVMP                                                                   ICU                                        Recovered, 32d                                                                                                                                         
  Gandolfini; Italy \[[@b25-anntransplant-25-e925755]\]       N/A                           25/45                       301                     Tac, MMF, Pred            Tac, MMF, stopped, Hydroxychloroquine, Abx, Lopinavir/ritonavir                                            None                                       Died, 5d                                                                                                                                               
                                                              832                           26/62                       718                     Tac, MMF, Pred            Tac, MMF, stopped, Abx, Hydroxychloroquine, Darunavir/cobicistat                                           None                                       Recovered, 8d                                                                                                                                          
  Guillen; Spain \[[@b26-anntransplant-25-e925755]\]          8900                          N/A                         N/A                     Tac, Pred, Eve            Tac, Eve stopped, Abx, hydroxychloroquine, Lopinavir/Ritonavir, INF-β                                      Both                                       Alive but suffers, 12d                                                                                                                                 
  Huang; China \[[@b27-anntransplant-25-e925755]\]            N/A                           N/A                         N/A                     MMF, Pred                 MMF, Pred stopped, Abx, oseltamivir, Lopinavir/ritonavir, IVMP                                             MV                                         Died, 40d                                                                                                                                              
  Ning; China \[[@b28-anntransplant-25-e925755]\]             N/A                           20/23 but elevated later    N/A                     MMF, Pred, CsA            No change in ISMs, Abx, lopinavir/ritonavir, IVIG                                                          None                                       Recovered, 12d                                                                                                                                         
  Seminari; Italy \[[@b29-anntransplant-25-e925755]\]         N/A                           14/22                       167 then 277            Tac, MMF                  No change in ISMs, Abx                                                                                     None                                       Recovered, 13d                                                                                                                                         
  Wang; China \[[@b30-anntransplant-25-e925755]\]             N/A                           N/A                         N/A                     MMF, Pred, CsA            No change in ISMs, INF-α, ribavirin, lopinavir/ritonavir IVMP                                              None                                       Recovered, 12d                                                                                                                                         
  Zhang; China \[[@b31-anntransplant-25-e925755]\]            185                           66/41                       193                     Tac, MMF, Pred            MMF stopped, Tac reduced, oseltamivir                                                                      None                                       Recovered, 16d                                                                                                                                         
                                                              630                           21/31                       180                     MMF, Pred                 ISMs stopped, Abx, oseltamivir                                                                             None                                       Alive but suffers, 7d                                                                                                                                  
                                                              1015                          70/49                       160                     Tac, MMF, Pred            Tac, MMF stopped, oseltamivir, IVIG                                                                        None                                       Recovered, 11d                                                                                                                                         
                                                              225                           7/26                        235                     Tac, MMF, Pred            ISMs stopped, oseltamivir                                                                                  None                                       Recovered, 19d                                                                                                                                         
                                                              195                           20/21                       248                     Tac, MMF, Pred            No change in ISMs, oseltamivir                                                                             None                                       Recovered, 7d                                                                                                                                          
  Zhu; China \[[@b32-anntransplant-25-e925755]\]              N/A                           30/29 but elevated later    N/A                     Tac, MMF, Pred            ISMs stopped, Abx, IVMP, IVIG, INF-α, GAD                                                                  None                                       Recovered, 18d                                                                                                                                         
  Arpali; Turkey \[[@b37-anntransplant-25-e925755]\]                                                                                            Tac, Pred                 No change in ISMs, oseltamivir                                                                             None                                       Recovered, 7d                                                                                                                                          
  Billa; USA \[[@b38-anntransplant-25-e925755]\]              1100                                                      285                     Tac, MMF, Pred            Tac reduced, IVMP,                                                                                         MV                                         Alive but suffers, 31d                                                                                                                                 
  Fontana; Italy \[[@b39-anntransplant-25-e925755]\]          N                                                         N                       Pred, CsA                 CsA stopped, Pred increased, Abx, Hydroxycloroquine, Tocilizumab, IVIG,                                    None                                       Recovered, 22d                                                                                                                                         
  Hsu; USA \[[@b40-anntransplant-25-e925755]\]                1124                          54/44                       361                     Tac, MMF, Pred            MMF stopped, hydroxychloroquine, remdesivir                                                                ICU                                        Recovered, 15d                                                                                                                                         
  Kates, USA \[[@b41-anntransplant-25-e925755]\]                                            34/48                                               Tac, MMF,                 MMF stopped, Tac reduced, Pred, Abx, chloroquine, hydroxychloroquine,                                      None                                       Recovered, 16d                                                                                                                                         
  Johnson; USA \[[@b42-anntransplant-25-e925755]\]                                                                                              Tac, MMF,                 Tac, MMF reduced, Abx, hydroxychloroquine,                                                                 None                                       Recovered, 23d                                                                                                                                         
  Kim; Korea \[[@b43-anntransplant-25-e925755]\]                                            35/32                                               Tac, MMF, Pred            Tac, MMF stopped, lopinavir/ritonavir, IVMP, hydroxychloroquine                                            None                                       Recovered, 23d                                                                                                                                         
                                                                                            10/14                                               Tac, MMF, Pred            MMF stopped, hydroxychloroquine, Abx,                                                                      None                                       Recovered, 17d                                                                                                                                         
  Fernández-Ruiz; Spain \[[@b44-anntransplant-25-e925755]\]                                                                                     Tac, Pred                 Tac reduced, lopinavir/ritonavir                                                                           None                                       Died, 5d                                                                                                                                               
                                                                                                                                                Tac, MMF, Pred            Tac reduced, MMF, Pred stopped, lopinavir/ritonavir, hydroxychloroquine, IVIG                              None                                       Alive but suffers, 23d                                                                                                                                 
                                                                                                                                                Tac, MMF, Pred            Tac reduced, MMF stopped, lopinavir/ritonavir, hydroxychloroquine                                          None                                       Alive but suffers, 28d                                                                                                                                 
                                                                                                                                                Tac, MMF, Pred            Tac reduced, MMF, Pred stopped, lopinavir/ritonavir, hydroxychloroquine, IVIG, IVMP                        None                                       Died, 16d                                                                                                                                              
                                                                                                                                                Tac                       Tac reduced, hydroxychloroquine, IVIG,                                                                     None                                       Alive but suffers, 9d                                                                                                                                  
                                                                                                                                                MMF, Pred, Srl            MMF stopped, hydroxychloroquine, IVMP                                                                      None                                       Recovered, 13d                                                                                                                                         
                                                                                                                                                Tac, Pred, Eve            Tac, Eve stopped, hydroxychloroquine, IVMP, Tocilizumab,                                                   None                                       Alive but suffers, 16d                                                                                                                                 
                                                                                                                                                Tac, MMF, Pred            Tac, MMF reduced, lopinavir/ritonavir, hydroxychloroquine                                                  None                                       Alive but suffers, 17d                                                                                                                                 
  Nair; USA \[[@b45-anntransplant-25-e925755]\]                                                                                                 Tac, MMF, Pred, Eve       No change in ISMs                                                                                          None                                       Recovered                                                                                                                                              
                                                                                                                                                Tac, MMF, Pred            MMF stopped, hydroxychloroquine, azithromycin                                                              None                                       Recovered                                                                                                                                              
                                                                                                                                                Tac, MMF                  MMF stopped, hydroxychloroquine, azithromycin, Abx                                                         None                                       Recovered                                                                                                                                              
                                                                                                                                                Tac, MMF, Pred            MMF stopped, hydroxychloroquine, azithromycin, Abx                                                         None                                       Recovered                                                                                                                                              
                                                                                                                                                Tac, MMF, Pred            Tac, MMF stopped, hydroxychloroquine, azithromycin, Abx                                                    Both                                       Died                                                                                                                                                   
                                                                                                                                                Tac, MMF                  Tac, MMF stopped, hydroxychloroquine, azithromycin, Abx, IVMP                                              Both                                       Recovered                                                                                                                                              
                                                                                                                                                Tac, MMF, Pred            MMF stopped, hydroxychloroquine, azithromycin, Abx, IVMP                                                   None                                       Recovered                                                                                                                                              
                                                                                                                                                Tac, MMF, Pred            MMF stopped, hydroxychloroquine, azithromycin, Abx                                                         ICU                                        Recovered                                                                                                                                              
                                                                                                                                                Pred, Srl                 Srl stopped, hydroxychloroquine, azithromycin                                                              Both                                       Died                                                                                                                                                   
                                                                                                                                                Tac, MMF                  MMF stopped, hydroxychloroquine, azithromycin, Abx, Pred                                                   Both                                       Died                                                                                                                                                   
  Zhu; China \[[@b46-anntransplant-25-e925755]\]                                            N                                                   Tac, MMF, Pred            No change in ISMs, Avx                                                                                     None                                       Recovered, 43d                                                                                                                                         
                                                                                            N                                                   Tac, MMF, Pred            MMF stopped, Tac reduced, IVIG, Avx                                                                        MV                                         Recovered, 48d                                                                                                                                         
                                                                                            N                                                   Tac, MMF, Pred            MMF stopped, IVMP, Avx                                                                                     None                                       Recovered, 37d                                                                                                                                         
                                                                                            N                                                   Tac, MMF, Pred            Tac, MMF stopped, IVIG, IVMP, Avx                                                                          None                                       Recovered, 37d                                                                                                                                         
                                                                                            104; N/A                                            Tac, MMF, Pred            Tac, MMF stopped, IVIG, IVMP, Avx                                                                          None                                       Recovered, 34d                                                                                                                                         
                                                                                            N                                                   Tac, MMF                  Tac, MMF stopped, IVIG, IVMP, Avx                                                                          MV                                         Alive but suffers, 49d                                                                                                                                 
                                                                                            94; N/N                                             Tac, MMF, Pred            Tac, MMF stopped, IVIG, IVMP, Avx                                                                          None                                       Recovered, 20d                                                                                                                                         
                                                                                            97; N/A                                             Tac, MMF                  Tac, MMF stopped, IVMP, Avx                                                                                None                                       Recovered, 34d                                                                                                                                         
                                                                                            61; N/A                                             CsA, mizoribine           ISMs stopped, IVIG, IVMP, Avx                                                                              MV                                         Died, 6d                                                                                                                                               
                                                                                            163; N/A                                            Tac, MMF, Pred            Tac, MMF stopped, IVIG, IVMP, Avx                                                                          None                                       Recovered, 31d                                                                                                                                         

Recovered indicates recovery of clinical symptoms and signs not negative COVID-19 testing;

Initial Creatinine (Cr) indicates Cr serum level in mg/dL unit before encountering COVID-19.

ISMs -- immunosuppressant medications; Max Temp -- maximum temperature; DOI -- duration of illness:; ICU -- Intensive Care Unit; MV -- mechanical ventilation; CRP -- C-reactive protein; WBCC -- white blood cell count; normal is 3.5--10 (×10^9^/L); NC -- neutrophil count, normal is 1.5--8 (×10^9^/L); LC -- lymphocyte count, normal is 1--3.5 (×10^9^/L); AKI -- acute kidney injury; Aza -- azathioprine; MMF -- mycophenolate mofetil; Tac -- tacrolimus; Pred -- prednisone; N/A -- not available; DCD -- donor after cardiac death; DBD -- donor after brain death; Abx -- antibiotics; Avx -- antivirals; V/D -- vomiting/diarrhea; PC -- Paracetamol; SLS -- Senior-Loken syndrome; LOS -- loss of appetite; IVMP -- intravenous methylprednisolone; IVIG -- intravenous immunoglobin; D -- Diarrhea; PTLD -- post-transplant lymphoproliferative disease; SP -- splenectomy; V -- vomiting; Eve -- everolimus:; INF-β -- interferon beta; CsA -- ciclosporin; N/V -- nausea/vomiting; INF-α -- interferon α; Abd.P -- abdominal pain; GAD -- glycyrrhizic acid diamine; CMV -- cytomegalovirus; HHA -- hereditary haemolytic anaemia; HD -- hemodialysis; LDH -- lactate dehydrogenase; ALT -- alanine aminotransferase; AST -- aspartate aminotransferase; LLS -- lupus-like syndrome; NMZL -- nodal marginal zone lymphoma; PD -- Parkinson disease; NB -- neurogenic bladder; DCM -- dilated cardiomyopathy; CAD -- coronary artery disease; OSA -- obstructive sleep apnea; CA -- cancer; Srl -- Sirolimus.

###### 

Clinical Characteristics for the 58 Reported Kidney Transplant Patients Who Encountered COVID-19.

  Variable (n=58)                             Value
  ------------------------------------------- ---------------------------
  Age (mean, range)                           52.69 (24--80)
  Sex                                         
   Male                                       44/58 (75.9%)
   Female                                     14/58 (24.1%)
  Kidney transplant years age (mean, range)   7.68 (0.083--31)
   Within 1 year                              9/58 (15.5%)
   Beyond 1 year                              49/58 (84.5%)
  Type of donor                               
   DCD                                        6/58 (10.3%)
   DBD                                        2/58 (3.4%)
   Deceased, unknown                          16/58 (27.5%)
   Living                                     9/58 (15.5%)
   Not available                              25/58 (43.1%)
  Comorbidities                               
   HTN                                        40/58 (68.9%)
   DM                                         21/58 (36.2%)
   CAD                                        6/58 (10.3%)
   COPD                                       2/58 (3.4%)
   Obesity                                    3/58 (5.2%)
   None                                       11/58 (18.9%)
  Clinical presentation                       
   Fever                                      49/58 (84.5%)
   Max. temp (average, SD)                    38.47 (±0.79)
   Chills                                     10/58 (17.2%)
   Cough                                      40/58 (70%)
   SOB                                        33/58 (56.9%)
   Chest pain/discomfort/tightness            4/58 (6.9%)
   Flu-like symptoms                          6/58 (10.3%)
   Fatigue                                    20/58 (34.5%)
   Myalgia                                    9/58 (15.5%)
   Vomiting                                   4/58 (6.9%)
   Diarrhea                                   10/58 (17.2%)
   Abdominal pain/bloating                    3/58 (5.2%)
   Nausea                                     3/58 (5.2%)
   Hyporexia/anorexia                         6/58 (10.3%)
   Headache                                   4/58 (6.9%)
   Dizziness                                  2/58 (3.4%)
   Sore throat                                3/58 (5.2%)
   Rhinorrhea/nasal congestion/stuffiness     5/58 (8.6%)
   Oliguria                                   2/58 (3.4%)
  Laboratory                                  
  White Cell Count                            
   Median (SD) per l                          6×10^9^ (±3.4×10^9^)
   Leukopenia (\<4×10^9^/l)                   8/35 (22.8%)
  Neutrophils count                           
   Median (SD) per l                          3.2×10^9^ (±3.9×10^9^)
   Neutropenia (\<1.5×10^9^/l)                1/13 (7.6%)
  Lymphocyte count                            
   Median (SD) per l                          0.6\*×10^9^ (±0.72×10^9^)
   Lymphopenia (\<1×10^9^/l)                  34/43 (79%)
  Initial C-reactive protein (CRP)            
   Median (SD)                                49 (±92.4)
   High CRP (\>5 mg/dl)                       36/37 (97.2%)
  Baseline serum creatinine (Cr)              
   Median (SD)                                1.65 (±0.96)
   High Cr (\>1.2 mg/dL)                      17/20 (85%)
  Initial serum Creatinine (Cr)               
   Median (SD)                                1.9 (±1.7)
   AKI                                        13/46 (28.2%)
  Initial D-dimer                             
   Median (SD)                                1015 (±2485)
   High D-dimer (\>500 μg/L)                  8/11 (72.7%)
  Initial ALT                                 
   Median (SD)                                34 (±39.8)
   High ALT (\>50 U/l)                        11/25 (44%)
  Initial AST                                 
   Median (SD)                                32 (±13.6)
   High AST (\>54 U/l)                        3/20 (15%)
  Initial lactate dehydrogenase (LDH)         
   Median (SD)                                266.5 (±311)
   High LDH (\>225 U/l)                       9/13 (69.2%)

###### 

Management and Outcomes of the 58 Reported Kidney Transplant Patients Who Encountered COVID-19.

  Variable                                 Value
  ---------------------------------------- ---------------------
  Baseline Immunosuppression               
   Tacrolimus                              48/58 (82.7%)
   Mycophenolate mofetil                   46/58 (79.3%)
   Prednisone                              47/58 (81%)
   Azathioprine                            2/58 (3.4%)
   Everolimus                              3/58 (5.2%)
   Ciclosporin                             4/58 (6.8%)
   Sirolimus                               2/58 (3.4%)
   Mizoribine                              1/58 (1.7%)
  Management                               
  Immunosuppression                        
   Held tacrolimus                         23/48 (47.9%)
   Reduced tacrolimus                      10/48 (20.8%)
   No change tacrolimus                    15/48 (25.8%)
   Held mycophenolate mofetil              37/46 (80.4%)
   Reduced mycophenolate mofetil           2/46 (4.3%)
   No change mycophenolate mofetil         7/46 (15.2%)
   Held prednisone                         7/47 (14.8%)
   Increased prednisone                    2/47 (4.2%)
   No change prednisone                    38/47 (80.8%)
   Azathioprine                            Held 1; No change 1
   Everolimus                              Held 2; No change 1
   Ciclosporin                             Held 2; No change 2
   Sirolimus                               Held 1; No change 1
   Mizoribine                              Held 1
  Other Tx                                 
   Lopinavir/Ritonavir                     12/58 (20.6%)
   Hydroxychloroquine                      25/58 (43.1%)
   Azithromycin                            9/58 (15.5%)
   Oseltamivir                             8/58 (13.8%)
   Antibiotics                             24/58 (41.3%)
   Intravenous methylprednisolone          19/58 (32.7%)
   Intravenous immunoglobulin              15/58 (25.8%)
   Unspecified antivirals                  10/58 (17.2%)
   Interferon α, β                         3/58 (5.2%)
   Tocilizumab                             2/58 (3.4%)
   Remdesivir                              1/58 (1.7%)
  ICU admission                            11/58 (19%)
  MV requirement                           13/58 (22.4%)
  Outcomes                                 
  Clinically recovered/Discharged          36/58 (62%)
   Illness days duration (median, Range)   17.5 (7--48)
   Alive but suffers/In hospital           13/58 (22.4%)
   Illness days duration (median, range)   14 (7--49)
  Death                                    9/58 (15.5%)
   Illness days duration (median, range)   9 (5--40)

###### 

Characteristics and management of the COVID-19 kidney transplant patients with death as the outcome.

  Variable (n=9)                          Value
  --------------------------------------- -------------
  Age in years (mean)                     66.2
   \>65y                                  55.5%
   \<65y                                  44.5%
  Sex, Male                               55.5%
  Kidney transplant years age (Mean)      9.7
  Comorbidities                           
   HTN                                    88.8%
   DM                                     33.3%
   COPD                                   100%
  Laboratories                            
   Lymphopenia (\<1\*10^9^/l)             66.6%
   High CRP (\>5 mg/dl)                   66.6%
   Acute kidney injury                    44.4%
  Baseline Immunosuppression regimen      
   Tac, MMF, Pred                         44.4%
  Management                              
  Immunosuppression                       
   Held tacrolimus                        3/6 (50%)
   Reduced tacrolimus                     2/6 (33.3%)
   No change tacrolimus                   1/6 (16.6%)
   Held mycophenolate mofetil             6/6 (100%)
   Held prednisone                        2/7 (28.5%)
   No change prednisone                   5/7 (71.4%)
   Held ciclosporin                       1/1 (100%)
   Held sirolimus                         1/1 (100%)
   Held mizoribine                        1/1 (100%)
  Tx targets COVID-19                     
   Lopinavir/Ritonavir                    44.4%
   Hydroxychloroquine                     55.5%
   Oseltamivir                            11.1%
   Antibiotics                            55.5%
   Intravenous methylprednisolone         33.3%
   Intravenous immunoglobulin             22.2%
  ICU admission                           33.3%
  MV requirement                          55.5%
  Disease days duration (median, range)   9 (5--40)

###### 

Clinical characteristics of the 58 reported kidney transplant patients who encountered covid-19 compared with previous published studies.

  Variable                              This study   Akalin et al. \[[@b47-anntransplant-25-e925755]\]   Alberici et al. \[[@b48-anntransplant-25-e925755]\]   CUKTP \[[@b49-anntransplant-25-e925755]\]   Pooled (mean)
  ------------------------------------- ------------ --------------------------------------------------- ----------------------------------------------------- ------------------------------------------- ---------------
  Number of patients                    58           36                                                  20                                                    15                                          129
  Age (mean)                            52.69                                                            59                                                    51                                          54.2
  Sex                                                                                                                                                                                                      
   Male                                 75.9%        72%                                                 80%                                                   67%                                         73.7%
   Female                               24.1%        28%                                                 20%                                                   33%                                         26.2%
  Kidney transplant years age (mean)    7.68                                                             13                                                    4                                           8.2
  Type of donor                                                                                                                                                                                            
   Deceased                             41.2%        75%                                                                                                       80%                                         65.4%
  Comorbidities                                                                                                                                                                                            
   HTN                                  68.9%        94%                                                 85%                                                                                               82.6%
   DM                                   36.2%        69%                                                 15%                                                                                               40%
   CAD                                  10.3%        17%                                                 15%                                                                                               14%
  Clinical presentation                                                                                                                                                                                    
   Fever                                84.5%        58%                                                 100%                                                  87%                                         82.3%
   Cough                                70%          53%                                                 50%                                                   60%                                         58%
   SOB                                  56.9%        44%                                                 5%                                                    27%                                         33.2%
   Fatigue                              34.5%                                                                                                                  27%                                         30.7%
   Myalgia                              15.5%        36%                                                 5%                                                    13%                                         17.3%
   Vomiting                             6.9%                                                                                                                   7%                                          6.9%
   Diarrhea                             17.2%        22%                                                                                                       20%                                         19.7%
   Sore throat                          5.2%                                                             10%                                                                                               7.6%
  Laboratory                                                                                                                                                                                               
  White cell count                                                                                                                                                                                         
   Mean per l (×10^9^)                  6            5.3                                                 5.4                                                   4.8                                         5.37
   Leukopenia (\<4×10^9^/l)             22.8%        21%                                                                                                                                                   21.9%
  Lymphocyte count                                                                                                                                                                                         
   Mean per l (×10^9^)                  0.6          0.6                                                 1.1                                                   0.8                                         0.77
   Lymphopenia (\<1×10^9^/l)            79%          79%                                                                                                                                                   79%
  Initial C-reactive protein (CRP)                                                                                                                                                                         
   Mean                                 49           7.9                                                 49                                                    104                                         52.4
   High CRP (\>5 mg/dl)                 97.2%        46%                                                                                                                                                   71.6%
  Initial serum Creatinine (Cr)                                                                                                                                                                            
   Mean                                 1.9                                                              1.8                                                                                               1.85
   AKI                                  28.2%                                                                                                                  40%                                         34.1%
  Initial D-dimer                                                                                                                                                                                          
   Mean                                 1015         1020                                                279                                                                                               771.3
   High D-dimer (\>500 μg/L)            72.7%        57%                                                                                                                                                   64.8%
  Initial lactate dehydrogenase (LDH)                                                                                                                                                                      
   Mean                                 266.5        336                                                 231                                                   275                                         277
   High LDH (\>225 U/l)                 69.2%        36%                                                                                                                                                   52.6%

###### 

Management and outcomes of the 58 reported kidney transplant patients who encountered COVID-19 compared with previous published studies.

  Variable                           This study   Akalin et al. \[[@b47-anntransplant-25-e925755]\]   Alberici et al. \[[@b48-anntransplant-25-e925755]\]   CUKTP \[[@b49-anntransplant-25-e925755]\]   Pooled (mean)
  ---------------------------------- ------------ --------------------------------------------------- ----------------------------------------------------- ------------------------------------------- ---------------
  Baseline Immunosuppression                                                                                                                                                                            
   Tacrolimus                        82.7%        97%                                                 95%                                                   93%                                         91.9%
   Mycophenolate mofetil             79.3%        86%                                                 70%                                                   80%                                         78.8%
   Prednisone                        81%          94%                                                 65%                                                   67%                                         77%
   Azathioprine                      3.4%                                                                                                                   7%                                          5.2%
  Management                                                                                                                                                                                            
  Immunosuppression                                                                                                                                                                                     
   Held tacrolimus                   47.9%        21%                                                                                                                                                   34.4%
   Held mycophenolate mofetil        80.4%        86%                                                                                                       71%                                         79.1%
  Other Tx                                                                                                                                                                                              
   Lopinavir/Ritonavir               20.6%                                                            79%                                                                                               49.8%
   Hydroxychloroquine                43.1%        86%                                                 95%                                                   86.6%                                       77.6%
   Azithromycin                      15.5%        46%                                                                                                       60%                                         40.5%
   Antibiotics                       41.3%                                                            55%                                                                                               48.1%
   Tocilizumab                       3.4%         7%                                                  30%                                                   7%                                          11.8%
  ICU admission                      19%                                                              20%                                                                                               20%
  MV requirement                     22.4%        39%                                                 10%                                                   27%                                         24.6%
  Outcomes                                                                                                                                                                                              
   Clinically recovered/Discharged   62%          36%                                                 15%                                                   53%                                         42%
   Alive but suffers/In hospital     22.4%        43%                                                 60%                                                   40%                                         41.3%
   Death                             15.5%        28%                                                 25%                                                   7%                                          18.8%
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